Induced differentiation affords neuroblastoma cells protection from hypoxic injury

Journal of Pediatric Surgery

Volumn 38, Issue 7, 2003, Pages 1069-1074

  Hoehner, Jeff C ^a,b   Prabhakaran, Kartik ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Differentiation; Hypoxia; Metabolic deprivation; Neuroblastoma; Quiescence

Indexed keywords

CYCLINE; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

EID: 0038337893     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(03)00195-7     Document Type: Article

References (23)

1. Brizel D, Sibley G, Prosnitz L, et al: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 3:285-259, 1978
2. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26:141-149, 1993
3. Hockel M, Schlenger K, Hockel S, et al: Tumor hypoxia in pelvic recurrences of cervical cancer. Int J Cancer 79:365-369, 1998
4. Kolstad P: Intercapillary distance, oxygen tension, and local recurrence in cervix cancer. Scand J Clin Lab Invest 106:145-157, 1968
5. Gatenby R, Kessler H, Rosenblum J, et al: Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14:831-838, 1988
6. Nordsmark M, Overgaard M, Overgaard J: Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41:31-39, 1996
7. Reynolds T, Rockwell S, Glazer P: Genetic instability induced by the tumor microenvironment. Cancer Res 56:5754-5757, 1996
8. Yuan J, Narayanan L, Rockwell S, et al: Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res 60:4372-4376, 2000
9. Durand RE: The influence of microenvironmental factors during cancer therapy. In Vivo 8:691-702, 1994
10. Brown J, Giaccia A: The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58:1408-1416, 1998
11. Grau C, Overgaard J: Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay. Radiother Oncol 13:301-309, 1988
12. Hoehner JC, Hedborg F, Sandstedt B, et al: Cellular death in neuroblastoma: In situ correlation of apoptosis and Bcl-2 expression. Int J Cancer 62:19-24, 1995
13. Hoehner JC, Gestblom C, Hedborg F, et al: A developmental model of neuroblastoma: Differentiating stroma-poor tumors progress along an extra-adrenal chromaffin lineage. Lab Invest 75:659-675, 1996
14. Hoehner JC, Gestblom C, Olsen L, et al: Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma. Br J Cancer 75:1185-1194, 1997
15. Hlatky L, Sachs R, Alpen E: Joint oxygen-glucose deprivation as the cause of necrosis in a tumor analog. J Cell Physiol 134:167-178, 1988
16. Hlatky L, Sachs R, Ring C: Reducing the hypoxic fraction of a tumour model by growth in low glucose. Br J Cancer 59:375-380, 1989
17. Påhlman S, Ruusala A-I, Abrahamsson L, et al: Retinoic acid-induced differentiation of cultured human neuroblastoma cells: A comparison with phorbol ester-induced differentiation. Cell Different 14:135-144, 1984
18. Slocum H, Pavelic Z, Kanter P, et al: The soft agar clonogenicity and characterization of cells obtained from human solid tumors by mechanical and enzymatic means. Cancer Chemother Pharmacol 6:219-225, 1981
19. Påhlman S, Hoehner JC, Nånberg E, et al: Differentiation and survival influences of growth factors in human neuroblastoma. Eur J Cancer 31A:453-458, 1995
20. Hall PA, Levison DA, Woods AL, et al: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 165:356-357, 1991
21. Villablanca J, Khan A, Avramis V, et al: Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J Clin Oncol 13:894-901, 1995
22. Hedborg F, Ohlsson R, Sandstedt B, et al: IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am J Pathol 146:833-847, 1995
23. Aebersold D, Burri P, Beer K, et al: Expression of hypoxia-inducible factor-1 alpha: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61:2911-2916, 2001